Interleukin-12 [clinicaltrials_resource:e4584a7670b1c3bf112f3a9cca379119]
A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3 [clinicaltrials:NCT00000857]A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients [clinicaltrials:NCT00000896]Treatment of Chronic Cryptosporidiosis in AIDS Patients [clinicaltrials:NCT00001128]Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection [clinicaltrials:NCT00001763]Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants [clinicaltrials:NCT00001906]Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections [clinicaltrials:NCT00001911]clinicaltrials:NCT00002952Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix [clinicaltrials:NCT00003017]clinicaltrials:NCT00003046Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors [clinicaltrials:NCT00003107]Interleukin-12 in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003149]Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease [clinicaltrials:NCT00003210]Interleukin-12 in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003330]Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00003339]Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation [clinicaltrials:NCT00003412]Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer [clinicaltrials:NCT00003439]Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003451]Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003575]Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer [clinicaltrials:NCT00004070]Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]clinicaltrials:NCT00004244Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma [clinicaltrials:NCT00004260]Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer [clinicaltrials:NCT00004893]Interleukin-12 Plus Interleukin-2 in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00005604]Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy [clinicaltrials:NCT00005779]clinicaltrials:NCT00015977Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00016289]Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00019188]Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00020449]Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma [clinicaltrials:NCT00026143]Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma [clinicaltrials:NCT00026182]Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors [clinicaltrials:NCT00028535]Interleukin-12 Gene Therapy in Treating Patients With Skin Metastases [clinicaltrials:NCT00028652]Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma [clinicaltrials:NCT00031733]Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides [clinicaltrials:NCT00052377]clinicaltrials:NCT00054405Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients [clinicaltrials:NCT00057486]Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer [clinicaltrials:NCT00072098]Biological Therapy in Treating Women With Breast Cancer That Has Spread to the Liver [clinicaltrials:NCT00301106]clinicaltrials:NCT00622401
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Interleukin-12 [clinicaltrials_resource:e4584a7670b1c3bf112f3a9cca379119]
Bio2RDF identifier
e4584a7670b1c3bf112f3a9cca379119
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e4584a7670b1c3bf112f3a9cca379119
identifier
clinicaltrials_resource:e4584a7670b1c3bf112f3a9cca379119
title
Interleukin-12
@en
type
label
Interleukin-12 [clinicaltrials_resource:e4584a7670b1c3bf112f3a9cca379119]
@en